Daewoong to license in Phenserine, an Alzheimer drug.

Published: 2006-01-19 06:56:00
Updated: 2006-01-19 06:56:00
Daewoong has agreed with Axonyx for the exclusive distribution of Phenserine (phenserine tartrate), an Alzheimer drug, in Korea.

The Phenserine's mode of pharmacological action is to block a production of beta amyloid, a toxic protein to accumulate in the brain to cause Schizophrenia as well a...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.